Minodronic Acid
- Product Name
- Minodronic Acid
- CAS No.
- 155648-60-5
- Chemical Name
- Minodronic Acid
- Synonyms
- Minodronic acid API;Minodronate Monohydrate;Minodronic Acid hydrate;MinodronateMonohydrate>Minodronic Acid Monohydrate;Minophosphonic acid monohydrate;CAS No.155648-60-5 Minodronic Acid;Minozonic acid/Minozonic acid monohydrate;1-Hydroxy-2-[imidazo[1,2-a]pyridin-3-yl]ethylidene-1,1-diphosphonic Acid;P,P'-(1-Hydroxy-2-imidazo[1,2-a]pyridin-3-ylethylidene)bisphosphonic acid hydrate
- CBNumber
- CB82521286
- Molecular Formula
- C9H14N2O8P2
- Formula Weight
- 340.163582
- MOL File
- 155648-60-5.mol
Minodronic Acid Property
- storage temp.
- 2-8°C
- Water Solubility
- Insoluble in water
- form
- powder to crystal
- color
- White to Light yellow to Light red
- InChI
- InChI=1S/C9H12N2O7P2.H2O/c12-9(19(13,14)15,20(16,17)18)5-7-6-10-8-3-1-2-4-11(7)8;/h1-4,6,12H,5H2,(H2,13,14,15)(H2,16,17,18);1H2
- InChIKey
- GPAPAOGRNKUFGH-UHFFFAOYSA-N
- SMILES
- C(P(O)(O)=O)(O)(P(O)(O)=O)CC1N2C(=NC=1)C=CC=C2.[H]O[H]
Safety
- RIDADR
- 2811
- RTECS
- SZ8562470
- HS Code
- 2933.99.8290
- HazardClass
- 6.1
- PackingGroup
- III
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H301Toxic if swalloed
H361Suspected of damaging fertility or the unborn child
- Precautionary statements
-
P201Obtain special instructions before use.
P202Do not handle until all safety precautions have been read and understood.
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P308+P313IF exposed or concerned: Get medical advice/attention.
P405Store locked up.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- M2360
- Product name
- Minodronate Monohydrate
- Purity
- >98.0%(HPLC)
- Packaging
- 25mg
- Price
- $207
- Updated
- 2024/03/01
- Product number
- Y0229
- Product name
- Minodronicacidmonohydrate
- Packaging
- 25mg
- Price
- $236
- Updated
- 2021/12/16
- Product number
- 38053
- Product name
- Minodronatemonohydrate,98%(HPLC)
- Purity
- 98%(HPLC)
- Packaging
- 25MG
- Price
- $275.52
- Updated
- 2021/12/16
- Product number
- 2663H
- Product name
- Minodronic Acid Hydrate
- Packaging
- 1g
- Price
- $390
- Updated
- 2021/12/16
- Product number
- DC8796
- Product name
- Minodronicacidmonohydrate
- Purity
- >98%
- Packaging
- 250mg
- Price
- $400
- Updated
- 2021/12/16
Minodronic Acid Chemical Properties,Usage,Production
Mechanism of action
Third-generation bisphosphonates, including minodronic acid hydrate, contain an amino group in the imidazole ring and are even more powerful inhibitors of bone resorption. With regard to inhibition of bone resorption, minodronic acid hydrate is 1000 times more effective than etidronate and 10–100 times more effective than alendronic acid. Following administration, minodronic acid hydrate specifically accumulates in the bone. It is then separated from the bone by acid released by osteoclasts during the bone resorption process and selectively taken up by osteoclasts. Conventional bisphosphonates were believed to inhibit bone resorption through the induction of osteoclast apoptosis after being taken up by these cells[1].
Clinical Use
The bone resorption inhibitor minodronic acid hydrate was approved and introduced last year in Japan, bringing the total number of bis-phosphonates marketed for this indication to seven. There are an estimated 10 million current and potential osteoporosis sufferers in Japan, a number that is expected to continue growing due to the country’s aging population. Minodronic acid is the first drug to show a significant effect in preventing bone fractures as compared to placebo in a Japanese patient population. Minodronic acid was co-developed by Astellas and Ono, who are marketing the drug as Bonoteo and Recalbon, respectively.
Synthesis
Several syntheses of minodronic acid have been reported,a scalable preparation is described in the scheme. Commercially available acid chloride 71 was first reduced with lithium tritertbutoxy aluminum hydride to the aldehyde 72 at 80??C in 61% yield. Next, reaction of aldehyde 72 with TMSCl and triethylamine generated the corresponding silyl enol ether, which was then treated with bromine to give a-bromoaldehyde 73 in 62% yield. Condensation with 2-amino pyridine furnished imidazopyridine 74, which was hydrolyzed with HCl to acid 75 in 58% yield. Reaction with H3PO3 at 120??C to provide minodronic acid hydrate (XII) in 53% yield.
References
[1] Shinji Tanishima, Yasuo Morio. “A review of minodronic acid hydrate for the treatment of osteoporosis.” Clinical Interventions in Aging 8 (2013): 185–9.
Minodronic Acid Preparation Products And Raw materials
Raw materials
Preparation Products
Minodronic Acid Suppliers
- Tel
- 800-4238616
- Fax
- +1-888-520-1075 / +1-503-283-1987
- sales@tciamerica.com
- Country
- Americas
- ProdList
- 23653
- Advantage
- 75
View Lastest Price from Minodronic Acid manufacturers
- Product
- Minodronic Acid 155648-60-5
- Price
- US $0.00/g
- Min. Order
- 10g
- Purity
- 99.0%
- Supply Ability
- 20kg/month
- Release date
- 2021-07-28
- Product
- Minodronate Monohydrate 155648-60-5
- Price
- US $1.00-0.00/KG
- Min. Order
- 1KG
- Purity
- 99%
- Supply Ability
- 50 tons
- Release date
- 2020-01-17
- Product
- Minodronic Acid 155648-60-5
- Price
- US $15.00-10.00/KG
- Min. Order
- 1KG
- Purity
- 99%+ HPLC
- Supply Ability
- Monthly supply of 1 ton
- Release date
- 2021-07-10